Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Astepro in children with allergic rhinitis
NCT01880840Phase 4Completed
- Sponsor
- Meda
- Start
- Jun 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azelastine in allergic rhinitis (AR), sponsored by Meda. Started Jun 2013; status: completed.
02
Drugs
azelastine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01880840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01880840.